Towa pharmaceutical company was founded in 1951, first president, Mr. Yoshida addressed, "We will contribute to people's health and we are dedicated to people’s genuine smile’’.
Actually, Towa has dealt with generic drugs since 1965 under Towa’s philosophy as professional manufacturer of generic drugs.
Generic drugs have the same efficacy and safety profile with original drugs so that generic drugs can contribute healthcare and society via inexpensive drug usage.
The idea to provide good quality, lower drug price will contribute to healthcare and society.
Towa’s philosophy is to value the "smile’ for patients, medical staff, medical personnel, and our company.
The business strategy is as below, for achievement Towa philosophy.
1. Stable supply …show more content…
In order to generate customer benefits, Towa Pharmaceutical Company’s strength is working on aggressive drug formulation and drug development, such as dry-syrup with less bitterness and development of OD tablets to take easily for children and even the elder.
Towa has a specific patent for OD tablet drug development. OD tablets are designed that can be drunk without water, and contained ingredients are the same as original drugs. Benefit can provide ease of taking drugs, anywhere, anytime. OD tablets have a benefit for patients, elderly people or children who are difficult to take drugs and when the patient family needs to support medication. Many patient groups such as the elderly, children, and patients who are mentally retarded, uncooperative, nauseated, or on reduced liquid-intake have difficulties swallowing these dosage forms.
In addition, Towa has strengths in original sales channels to hospitals and pharmacies. Apart from the general wholesaler method, it has a system to sell directly. By utilizing both, it is expected that Towa can cover customers more quickly and widely compared to …show more content…
Competitors acquire overseas companies and are building up overseas bases. It seems that the sluggish growth of the domestic market in the future is predicted. In overseas expansion, each country has strict drug screening, and drug design must be conducted according to the each country conditions. Therefore, it is impossible to have new markets (overseas) and existing products (already released products). New markets (overseas) - While new products are attractive in diversification, they also have
Actually, Towa has dealt with generic drugs since 1965 under Towa’s philosophy as professional manufacturer of generic drugs.
Generic drugs have the same efficacy and safety profile with original drugs so that generic drugs can contribute healthcare and society via inexpensive drug usage.
The idea to provide good quality, lower drug price will contribute to healthcare and society.
Towa’s philosophy is to value the "smile’ for patients, medical staff, medical personnel, and our company.
The business strategy is as below, for achievement Towa philosophy.
1. Stable supply …show more content…
In order to generate customer benefits, Towa Pharmaceutical Company’s strength is working on aggressive drug formulation and drug development, such as dry-syrup with less bitterness and development of OD tablets to take easily for children and even the elder.
Towa has a specific patent for OD tablet drug development. OD tablets are designed that can be drunk without water, and contained ingredients are the same as original drugs. Benefit can provide ease of taking drugs, anywhere, anytime. OD tablets have a benefit for patients, elderly people or children who are difficult to take drugs and when the patient family needs to support medication. Many patient groups such as the elderly, children, and patients who are mentally retarded, uncooperative, nauseated, or on reduced liquid-intake have difficulties swallowing these dosage forms.
In addition, Towa has strengths in original sales channels to hospitals and pharmacies. Apart from the general wholesaler method, it has a system to sell directly. By utilizing both, it is expected that Towa can cover customers more quickly and widely compared to …show more content…
Competitors acquire overseas companies and are building up overseas bases. It seems that the sluggish growth of the domestic market in the future is predicted. In overseas expansion, each country has strict drug screening, and drug design must be conducted according to the each country conditions. Therefore, it is impossible to have new markets (overseas) and existing products (already released products). New markets (overseas) - While new products are attractive in diversification, they also have